Our management team is one of the most experienced in genome editing and the cell and gene therapy industry.

Sandy Macrae, M.B., Ch.B., Ph.D.

President and CEO

Ward Wolff

Executive Vice President and CFO

Dale Ando, M.D.

Vice President, Therapeutic Development and CMO

Shirley Clift

Vice President, Regulatory Affairs

Nathalie Dubois-Stringfellow, Ph.D.

Vice President, Product Development and Management

Mohammad El-Kalay, Ph.D.

Vice President, Technical Operations

Curt Herberts

Vice President, Corporate Development

Michael Holmes, Ph.D.

Vice President, Research

Edward Rebar, Ph.D.

Vice President, Technology

Elizabeth Wolffe, Ph.D.

Vice President, Corporate Communications